An activist investor has approached H.B. Fuller with a cash offer to acquire the company’s Building Adhesive Solutions business for up to $1.2 billion. Ancora Holdings communicated the proposal in a letter to H.B. Fuller’s board on Wednesday, urging the company to evaluate the potential sale as a path that would serve both the firm and its shareholders.
In its letter, Ancora said it had contacted H.B. Fuller’s chief executive and chairman privately in early July to discuss a possible transaction but that those outreach efforts did not produce a meaningful response. The investment firm accused H.B. Fuller’s leadership of placing entrenchment ahead of shareholder interests and indicated it stood ready to sign a confidentiality agreement and proceed with due diligence without delay.
Ancora framed the proposed divestiture as an opportunity for H.B. Fuller to concentrate management resources on integrating Advanced Medical Solutions, and to exit what Ancora described as a low-margin business operating in a fragmented market. The activist highlighted the strategic logic of narrowing focus toward the medical-supplies side of the company’s operations.
Earlier this year, H.B. Fuller agreed to acquire Advanced Medical Solutions Group in a cash deal valued at approximately A3715 million, including debt. Ancora, which disclosed a stake in H.B. Fuller amounting to more than 2% in May, had previously criticized that medical-supplier acquisition as an "irresponsible pursuit" and urged H.B. Fuller to abandon the transaction.
The proposal from Ancora comes against a backdrop of activist pressure in the chemicals and specialty materials industry. The firm has also pressed chemical maker Ashland to consider a sale, indicating Ancoras broader push for strategic changes at companies where it holds stakes.
Ancoras offer is structured as an all-cash proposal for the Building Adhesive Solutions unit. The investor asserted that divesting the unit would free H.B. Fuller to focus on integrating its newly acquired medical business while shedding a segment Ancora characterized as lower margin and fragmented.
At the time of its letter, Ancora signaled it was prepared to move quickly, offering to execute confidentiality paperwork and begin a formal diligence process immediately if the board engages. H.B. Fullers response to the overture and any subsequent negotiations were not detailed in Ancoras correspondence as described in the letter.
What this means
- Ancora has proposed up to $1.2 billion in cash for H.B. Fullers Building Adhesive Solutions business.
- The investor says the sale would enable H.B. Fuller to focus on integrating Advanced Medical Solutions and exit a low-margin, fragmented segment.
- Ancora disclosed a stake of greater than 2% in H.B. Fuller in May and previously criticized the Advanced Medical Solutions acquisition as "irresponsible." The firm has also targeted Ashland with calls for strategic change.